Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zybec Biopharma is a biotechnology company based in Gaithersburg, Maryland, that specializes in the development of innovative vaccines and recombinant protein therapeutics. The company focuses on addressing global health challenges by leveraging its proprietary protein expression platform to create high-quality, cost-effective medical solutions. Zybec maintains a close strategic relationship with Bharat Biotech International, serving as a key partner for research, development, and clinical advancement of vaccine candidates. Their portfolio primarily targets infectious diseases, with significant programs dedicated to malaria and emerging viral threats. By combining advanced bioprocessing technologies with global manufacturing partnerships, Zybec aims to improve healthcare accessibility in underserved regions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ZYBEC.